Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Operating Leases (2020 - 2025)

Journey Medical's Operating Leases history spans 6 years, with the latest figure at $18000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Operating Leases fell 84.75% year-over-year to $18000.0, compared with a TTM value of $18000.0 through Dec 2025, down 84.75%, and an annual FY2025 reading of $18000.0, down 84.75% over the prior year.
  • Operating Leases for Q4 2025 was $18000.0 at Journey Medical, down from $44000.0 in the prior quarter.
  • The five-year high for Operating Leases was $118000.0 in Q4 2024, with the low at $9000.0 in Q4 2023.
  • Average Operating Leases over 5 years is $60090.9, with a median of $59000.0 recorded in 2023.
  • Year-over-year, Operating Leases crashed 91.67% in 2023 and then surged 1211.11% in 2024.
  • Tracing DERM's Operating Leases over 5 years: stood at $24000.0 in 2021, then skyrocketed by 350.0% to $108000.0 in 2022, then crashed by 91.67% to $9000.0 in 2023, then surged by 1211.11% to $118000.0 in 2024, then crashed by 84.75% to $18000.0 in 2025.
  • Per Business Quant, the three most recent readings for DERM's Operating Leases are $18000.0 (Q4 2025), $44000.0 (Q3 2025), and $69000.0 (Q2 2025).